New highs on the NYSE have continued to expand at a strong rate. They have dominated the number of new lows, and so this indicator remains bullish for stocks. Yesterday, there were more than 200 new ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

What Happened? A number of stocks fell in the morning session after an unexpectedly sharp rise in wholesale inflation fueled ...

What Happened? A number of stocks fell in the morning session after an unexpectedly sharp rise in wholesale inflation fueled ...

The stock market's on pace to snap a three-day winning streak after an inflation report nudged some investors to pare back rate cut hopes.

A number of stocks fell in the afternoon session after markets pulled back amid hotter-than-expected inflation data. The main ...

Potential challenges that could lead to underperformance include fluctuations in commodity prices, regulatory changes, or unexpected operational issues. If Energy Transfer fails to meet its guidance, ...

What Happened: Logan's recent move involves selling 500,000 shares of Mirion Technologies. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

President Trump's tariffs continue to affect global markets and the economy. Follow for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...

S&P 500 and Nasdaq hold near highs as traders await PPI and jobless claims. Mixed earnings and Fed outlook shape today’s US stock market forecast.

At least that’s what Wall Street’s fear gauge suggests. The VIX plunged to its lowest point of 2025 on Wednesday, just above 14 — roughly 30 percent below its long-run average of 20 — while the S&P ...

The stock market is increasingly optimistic about Pro Medicus shares after it reported record FY 2025 results.